Our previous study also revealed that EYA4 expression is repressed in human pancreatic ductal adenocarcinoma and mediates tumor-suppressive effects by abolishing the β-catenin Ser675-dependent transactivation of inhibitor of DNA binding 2 (ID2) [22]. Here, EYA4 is linked to neoplasm.